Evidence map›Paper›PMID 40630214›Full record

ArticleFrontiers in oncology2025

Global trends in esophageal cancer: sex and age disparities in health inequalities from 1990 to 2021, with projections to 2050.

Ying Liu, Erman Wu, Fang Cheng, Meng Zhang, Qian Rou, Zenati Nuertai, Maorong Xu, Shanshan Xu, Minghui Li, Lei Zhang and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ying Liu *Special Needs Comprehensive Department, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Erman Wu *Department of Neurosurgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Fang ChengSpecial Needs Comprehensive Department, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Meng ZhangSpecial Needs Comprehensive Department, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Qian RouSpecial Needs Comprehensive Department, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Zenati NuertaiSpecial Needs Comprehensive Department, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Maorong XuSpecial Needs Comprehensive Department, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Shanshan XuSpecial Needs Comprehensive Department, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Minghui LiSpecial Needs Comprehensive Department, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Lei ZhangSpecial Needs Comprehensive Department, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Aheli NasiroulaSpecial Needs Comprehensive Department, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Esophageal cancer remains one of the deadliest cancers globally, highlighting significant health challenges and socioeconomic disparities. This study aims to measure its global burden, assess disparities by sex, age, and region, and evaluate health inequalities, with projections to 2050. The goal is to provide evidence to guide resource allocation and reduce the disease burden. Methods: Using data from the Global Burden of Disease (GBD) 2021 study, we analyzed trends in prevalence, incidence, mortality, and Disability-Adjusted Life Years (DALYs) across sexes, age groups, and 204 countries and territories. Age-standardized rates (ASR) were calculated to account for population age structures. Trends over time were assessed using the estimated annual percentage change (EAPC). Health inequalities were evaluated using the Slope Index of Inequality (SII) and Concentration Index (CI). Future burdens were projected using Bayesian Age-Period-Cohort (BAPC) models. Results: From 1990 to 2021, esophageal cancer cases increased: prevalence from 551.62 to 1004.2 thousand, incidence from 354.73 to 576.53 thousand, mortality from 356.26 to 538.6 thousand, and DALYs from 9753.57 to 12999.26 thousand. However, age-standardized rates declined: prevalence from 13.34 to 11.47, incidence from 8.86 to 6.65, mortality from 9.02 to 6.25, and DALYs from 235.32 to 148.56 per 100,000 people. The burden rises sharply after age 40, with males and low-SDI regions experiencing higher burdens. Health inequalities widened, with the SII for prevalence increasing from 2.52 to 5.67, and for deaths from 1.45 to 2.94. West Africa, North Europe, and North America saw rising prevalence rates, while East Asia showed a declining trend. A decreasing trend is observed in most countries and regions worldwide, particularly in East Asia, with projections suggesting a continued decline in the future. Conclusion: Although projections indicate a decreasing trend, health inequalities have intensified. Regions such as West Africa, North Europe, and North America are experiencing rising prevalence. To address these disparities, targeted interventions, enhanced healthcare access, and preventive measures in high-burden areas are essential to reduce the global burden and advance health equity.

Indexed as

age disparitiesdisease projectionsesophageal cancerglobal burden of diseasehealth inequalitiessex disparitiessociodemographic index

Identifiers

PMID40630214
PMCPMC12234333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.